Sangamo Therapeutics, Inc. Common Stock (SGMO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. SGMO | Sangamo Therapeutics Inc. Analyst Estimates ... Nov 09, 2019 · Sangamo Therapeutics Inc. analyst estimates by MarketWatch. View SGMO revenue estimates and earnings estimates, as well as analyst recommendations. SGMO | Sangamo Therapeutics Inc. Analyst Estimates ... Sangamo Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SGMO updated stock price target summary. SGMO Stock Quote - Sangamo Therapeutics, Inc. Common Stock ...
SGMO - Sangamo Therapeutics Inc Stock quote - CNNMoney.com
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The Do Analysts Recommend You Should Buy Sangamo Therapeutics ... Mar 03, 2020 · On Monday, shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) marked $8.50 per share versus a previous $8.53 closing price. With having a -0.35% loss, an insight into the fundamental values of Sangamo Therapeutics, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. Ideas and Forecasts on SANGAMO THERAPEUTICS INC — … Look for sustained rally upwards from 50 day average, powerfull buy signal could be triggered and could move the stock closer to its consensus price target of $13.50 www.smarteranalyst.com NASDAQ:SGMO SGMO Sangamo Therapeutics, Inc. Stock Quote
SGMO | Complete Sangamo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Investment analysts at H.C. Wainwright published a research note on August 26, 2019 where it informed investors and clients that Sangamo Therapeutics Inc. (NASDAQ:SGMO) is now rated as Buy. Their price target on the stock stands at $16. Even though the stock has been trading at $7.44/share, analysts expect it to down by -4.97% to reach $18.80 SANGAMO THERAPEUTICS, INC. : SGMO Stock Price | … Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation Is Sangamo's (SGMO) Stock Price Collapse Justified? Sep 06, 2018 · While encouraging, Moussatos is not willing to bet on SGMO. The analyst rates the stock a Neutral, while raising her price target to $11.00 (from $10.00), which implies a 17% downside potential
Analyzing Sangamo Therapeutics (NASDAQ:SGMO) stock? View SGMO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.
Sangamo Therapeutics, Inc. - SGMO - Stock Price Today - Zacks View Sangamo Therapeutics, Inc. SGMO investment & stock information. Get the latest Sangamo Therapeutics, Inc. SGMO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Case for Further Gains in Onconova Therapeutics (ONTX ... Mar 16, 2020 · Based on the latest results, analysts are suggesting that the target price for SGMO stock should be $6.67 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, SGMO should have a spike by 0% in oppose to its present value in the market. Sangamo Therapeutics, Inc. (SGMO) Price - Zacks.com Price is a widely used stock evaluation measure. Find the latest Price for Sangamo Therapeutics, Inc. (SGMO) Sangamo Therapeutics, Inc. (SGMO) Price - Zacks.com
Sangamo Therapeutics, Inc. Common Stock (SGMO) Analyst ...
Sangamo Therapeutics Price Target | SGMO View Price Target for SGMO Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. HC Wainwright Reaffirms Buy Rating for Sangamo ... HC Wainwright reiterated their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO) in a report issued on Monday morning, AnalystRatings.com reports. HC Wainwright currently has a $16.00 target price on the biopharmaceutical company’s stock. Sangamo Therapeutics, Inc. - SGMO - Stock Price Today - Zacks View Sangamo Therapeutics, Inc. SGMO investment & stock information. Get the latest Sangamo Therapeutics, Inc. SGMO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Case for Further Gains in Onconova Therapeutics (ONTX ...
Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing. SGMO Sangamo Therapeutics, Inc. Common Stock - NASDAQ.com